- Home
- CLLS vs EFR Comparison
CLLS vs EFR Comparison
Compare CLLS & EFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLLS | EFR |
|---|---|---|
| Founded | 1999 | 2003 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 299.0M | 327.1M |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | CLLS | EFR |
|---|---|---|
| Price | $4.39 | $11.04 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 132.4K | 88.6K |
| Earning Date | 11-07-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.43% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.69 |
| Revenue | ★ $82,551,000.00 | N/A |
| Revenue This Year | $32.58 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.74 |
| Revenue Growth | ★ 129.04 | N/A |
| 52 Week Low | $1.10 | $10.95 |
| 52 Week High | $5.48 | $13.29 |
Technical Indicators
Market Signals| Indicator | CLLS | EFR |
|---|---|---|
| Relative Strength Index (RSI) | 49.34 | 36.46 |
| Support Level | $4.47 | $11.14 |
| Resistance Level | $5.45 | $11.24 |
| Average True Range (ATR) | 0.30 | 0.08 |
| MACD | -0.12 | -0.01 |
| Stochastic Oscillator | 31.17 | 10.87 |
Price Performance
Historical ComparisonAbout CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About EFR Eaton Vance Senior Floating-Rate Fund of Beneficial Interest
Eaton Vance Senior Floating Rate Trust is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income. As a secondary objective, the fund intends to seek capital preservation. Its portfolio of investments consists of Software, Health Care Providers & Services, Machinery, Chemicals, Professional Services, IT Services, Hotels, Restaurants & Leisure, Capital Markets, Specialty Retail, Commercial Services & Supplies, and other areas. The trust invests in below investment grade floating rate loans, which are considered speculative because of the credit risk of their issuers.